218 related articles for article (PubMed ID: 26638944)
1. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
Marzese DM; Witz IP; Kelly DF; Hoon DS
Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
[TBL] [Abstract][Full Text] [Related]
2. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
Marzese DM; Scolyer RA; Huynh JL; Huang SK; Hirose H; Chong KK; Kiyohara E; Wang J; Kawas NP; Donovan NC; Hata K; Wilmott JS; Murali R; Buckland ME; Shivalingam B; Thompson JF; Morton DL; Kelly DF; Hoon DS
Hum Mol Genet; 2014 Jan; 23(1):226-38. PubMed ID: 24014427
[TBL] [Abstract][Full Text] [Related]
3. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights.
Gómez S; Castellano G; Mayol G; Suñol M; Queiros A; Bibikova M; Nazor KL; Loring JF; Lemos I; Rodríguez E; de Torres C; Mora J; Martín-Subero JI; Lavarino C
Epigenomics; 2015 Oct; 7(7):1137-53. PubMed ID: 26067621
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic Reprogramming as a Driver of Malignant Glioma.
Phillips RE; Soshnev AA; Allis CD
Cancer Cell; 2020 Nov; 38(5):647-660. PubMed ID: 32916125
[TBL] [Abstract][Full Text] [Related]
6. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
[TBL] [Abstract][Full Text] [Related]
7. Cell-of-origin chromatin organization shapes the mutational landscape of cancer.
Polak P; Karlić R; Koren A; Thurman R; Sandstrom R; Lawrence M; Reynolds A; Rynes E; Vlahoviček K; Stamatoyannopoulos JA; Sunyaev SR
Nature; 2015 Feb; 518(7539):360-364. PubMed ID: 25693567
[TBL] [Abstract][Full Text] [Related]
8. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
[TBL] [Abstract][Full Text] [Related]
9. RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis.
Sato R; Nakano T; Hosonaga M; Sampetrean O; Harigai R; Sasaki T; Koya I; Okano H; Kudoh J; Saya H; Arima Y
Biomed Res Int; 2017; 2017():8032910. PubMed ID: 28210624
[TBL] [Abstract][Full Text] [Related]
10. Discovery and development of DNA methylation-based biomarkers for lung cancer.
Walter K; Holcomb T; Januario T; Yauch RL; Du P; Bourgon R; Seshagiri S; Amler LC; Hampton GM; S Shames D
Epigenomics; 2014 Feb; 6(1):59-72. PubMed ID: 24579947
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
Grady WM; Yu M; Markowitz SD
Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
[TBL] [Abstract][Full Text] [Related]
13. Chromatin Profiling Techniques: Exploring the Chromatin Environment and Its Contributions to Complex Traits.
Chawla A; Nagy C; Turecki G
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299232
[TBL] [Abstract][Full Text] [Related]
14. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic biomarkers.
Chan TA; Baylin SB
Curr Top Microbiol Immunol; 2012; 355():189-216. PubMed ID: 21818705
[TBL] [Abstract][Full Text] [Related]
16. [Molecular background of the melanoma and the brain metastasis].
Katona F; Murnyák B; Marko-Varga G; Hortobágyi T
Orv Hetil; 2017 Jul; 158(28):1083-1091. PubMed ID: 28691878
[TBL] [Abstract][Full Text] [Related]
17. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
[TBL] [Abstract][Full Text] [Related]
18. Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter.
Redmer T
Mol Cancer; 2018 Jul; 17(1):106. PubMed ID: 30053879
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Liu S; Ren S; Howell P; Fodstad O; Riker AI
Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of human non-coding RNA gene transcription.
Morselli M; Dieci G
Biochem Soc Trans; 2022 Apr; 50(2):723-736. PubMed ID: 35285478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]